Photoscreening for amblyopia risk factors assessment in young children: A systematic review with meta-analysis

Eur J Ophthalmol. 2023 Jan;33(1):92-103. doi: 10.1177/11206721221099777. Epub 2022 May 6.

Abstract

Purpose: Amblyopia is a leading cause of preventable and treatable vision loss in the pediatric population. Instrument-based screening of amblyopia-risk factors is being widely adopted but the audit of its results is still lacking. We sought to review the existing evidence regarding the outcomes of photoscreening applied to children under the age of three years.

Methods: A three-database search (Pubmed, ISI Web of Science, and Scopus) was performed from inception to March 2021. A meta-analysis of proportions was conducted to summarize the referral rate, untestable rate and positive predictive value (PPV).

Results: Thirteen studies were selected among 705 original abstracts. The quantitative analysis included twelve studies enrolling 64,041 children. Of these, 13% (95%CI: 7-19%) were referred for further confirmation of the screening result. Astigmatism was the most common diagnosis both after screening and after ophthalmologic assessment of referred children. The pooled untestable rate and PPV were 8% (95%CI: 3-15%) and 56% (95%CI: 40-71%), respectively.

Conclusion: There is no global consensus on the optimal age, frequency or what magnitude of refractive error must be considered an amblyopia-risk factor. Optimization of referral criteria is therefore warranted.

Keywords: Amblyopia; photoscreening; preverbal child; refractive error; strabismus.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Amblyopia* / diagnosis
  • Amblyopia* / epidemiology
  • Child
  • Child, Preschool
  • Humans
  • Refractive Errors* / diagnosis
  • Reproducibility of Results
  • Risk Factors
  • Sensitivity and Specificity
  • Vision Disorders
  • Vision Screening* / methods